Evidence map›Paper›PMID 22817734›Full record

ReviewBiochemical Society transactions2012

How does Tra2β protein regulate tissue-specific RNA splicing?

David J Elliott, Andrew Best, Caroline Dalgliesh, Ingrid Ehrmann, Sushma Grellscheid

Open access · bronzeAbstract readReview
In one paragraph

Review in Biochemical Society transactions, 2012. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 16 papers.

0numbers the graph read from it
0cells of the map it votes in
16citing papers in PubMed
1.3field-weighted citation impact, top 20% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

16 citing papers in PubMed, 20 citations in OpenAlex.

  1. Article
  2. Review
  3. Review
  4. Article
  5. Review
  6. Article
  7. Review
  8. Review
  9. Article
  10. Article
  11. Article
  12. Splicing factor TRA2B is required for neural progenitor survival.The Journal of comparative neurology · 2014
    Article
  13. Article
  14. Article
  15. Article
  16. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

5 authors at 1 institution in 1 country.

David J ElliottInstitute of Genetic Medicine, Newcastle University, Central Parkway, Newcastle upon Tyne, UK. David.Elliott@ncl.ac.uk
Andrew Best
Caroline Dalgliesh
Ingrid Ehrmann
Sushma Grellscheid
Newcastle University · GB

Funding

Biotechnology and Biological Sciences Research Council BB/D013917/1Biotechnology and Biological Sciences Research Council BB/I006923/1Breast Cancer Now 2009NOVPHD21Wellcome Trust 080368Wellcome Trust 089225Wellcome Trust WT080368MAWellcome Trust WT089225/Z/09/Z
6 · The paper itself

Abstract

The splicing regulator protein Tra2β is conserved between humans and insects and is essential for mouse development. Recent identification of physiological RNA targets has started to uncover molecular targets and mechanisms of action of Tra2β. At a transcriptome-wide level, Tra2β protein binds a matrix of AGAA-rich sequences mapping frequently to exons. Particular tissue-specific alternatively spliced exons contain high concentrations of high scoring Tra2β-binding sites and bind Tra2β strongly in vitro. These top exons were also activated for splicing inclusion in cellulo by co-expression of Tra2β protein and were significantly down-regulated after genetic depletion of Tra2β. Tra2β itself seems to be fairly evenly expressed across several different mouse tissues. In the present paper, we review the properties of Tra2β and its regulated target exons, and mechanisms through which this fairly evenly expressed alternative splicing regulator might drive tissue-specific splicing patterns.

Indexed as

Alternative SplicingAnimalsHumansNerve Tissue ProteinsRNARNA-Binding ProteinsSerine-Arginine Splicing FactorsNerve Tissue ProteinsRNARNA-Binding ProteinsSerine-Arginine Splicing FactorsTRA2B protein, human

Identifiers

PMID22817734
PMCPMC3950818
OpenAlexW2172152062

What OpenQuestion holds

Textmetadata
LicenceTDM
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.